Jeffrey Huber Overview
- Investor Type
-
Angel
- Status
-
Active
- Investments
-
14
- Portfolio
-
8
- Exits
-
5
Jeffrey Huber General Information
Description
Mr. Jeffrey Huber is a Co-Founder and serves as General Partner at Triatomic Capital. He also serves as a Board Member at Summit Therapeutics. He is an Angel Investor. He co-founded and served as Vice Chairman at GRAIL. He serves as a Board Member at Electronic Arts. He serves as Chairman at Mammoth Biosciences. He serves as a Board Member at Manifold Bio, Upstart. He served as a Board Member at Ancestry. He serves as Chairman at Genalyte. He serves as a Board Member at Zapata Computing. He serves as a Board Member at Openwater. He is an Advisor of StrongBlock. Before Grail, he worked at the intersection of life sciences and computer science at Google. Previously at Google, he led development for Google Ads, Google Apps, and Google Maps. He holds a bachelor's degree in Computer Engineering from the University of Illinois and a master's degree from Harvard University. He is a Board member & Member of the Audit Committee of Electronic Arts (EA) Board Member of The Exploratorium and a former board member of Illumina. He has also served as an Advisor at Blue Horizon Equity. He serves as a Board Member at d-Matrix.
Business Details
Website
profiles.google.com/jhuberYear Founded
Investor Status
Primary Investor Type
Corporate Office
- 2950 South Delaware Street
- Suite 410
- San Mateo, CA 94403
- United States
Jeffrey Huber Investments (14)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Synapticure | 01-Feb-2022 | Seed Round | Clinics/Outpatient Services | Generating Revenue | ||
Superhuman | 27-Jun-2019 | Business/Productivity Software | Generating Revenue | |||
Openwater | 10-Dec-2018 | Diagnostic Equipment | Startup | |||
Honor | 20-Sep-2018 | Information Services (B2C) | Generating Revenue | |||
Atomwise | 02-Jul-2018 | Drug Discovery | Pre-Clinical Trials | |||
Kiavi | 12-Mar-2018 | Specialized Finance | Generating Revenue | |||
Vir | 06-Jan-2017 | Drug Discovery | Generating Revenue/Not Profitable | |||
Razorpay | 26-Oct-2015 | Financial Software | Generating Revenue | |||
Atomwise | 05-May-2015 | Seed Round | Drug Discovery | Pre-Clinical Trials | ||
Poshmark | 21-Apr-2015 | Later Stage VC | Internet Retail | Profitable |
Jeffrey Huber Exits (5)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Caribou Biosciences | 23-Jul-2021 | IPO | |
Zymergen | 22-Apr-2021 | ||
Poshmark | 14-Jan-2021 | ||
UXPin | 09-Jun-2020 | Buyout/LBO | |
Vir | 11-Oct-2019 | IPO |
Jeffrey Huber Investments by Industry, Year, and Region
Jeffrey Huber Co-Investors (17)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
GV | 1 | ||||
Joe Kraus | |||||
Martin Ventures | |||||
Ronald Conway | |||||
Sandro Salsano |
Jeffrey Huber FAQs
-
Who is Jeffrey Huber?
Jeffrey Huber is an angel Investor who has made 14 investments.
-
What kind of investor is Jeffrey Huber?
Jeffrey Huber is an angel investor.
-
What does Jeffrey Huber do?
As an angel investor, Jeffrey Huber invests personal money into promising companies, typically in exchange for equity.
-
How many board seats does Jeffrey Huber hold?
Jeffrey Huber holds 7 board seats including Summit Therapeutics, d-Matrix, Upstart Holdings, Openwater, and Electronic Arts.
-
What has Jeffrey Huber invested in?
Jeffrey Huber has made numerous investments in companies like Synapticure, Superhuman, and Openwater within the Clinics/Outpatient Services, Business/Productivity Software, and Diagnostic Equipment industries.
-
What has Jeffrey Huber invested in recently?
Jeffrey Huber's latest investment was on 01-Feb-2022 in Synapticure, a company within the Clinics/Outpatient Services industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »